Michelle Basye, NP
Nurse Practitioner · Beloit, WINPI 1366143968
Payments from drug & device makers
Across 134 payments — averaging $21.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$412
- Merck$292
- Johnson & Johnson$242
- AstraZeneca$196
- Bayer$181
- Lilly USA, LLC$148
- plus $1K from 35 others
What the payments were for
- Food & beverage$2,73696%
- Education$1104%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 28 | $412 |
| Merck | 8 | $292 |
| Johnson & Johnson | 11 | $242 |
| AstraZeneca | 10 | $196 |
| Bayer | 8 | $181 |
| Lilly USA, LLC | 3 | $148 |
| AbbVie | 6 | $134 |
| Astellas Pharma US Inc | 6 | $133 |
| Regeneron Healthcare Solutions, Inc. | 6 | $117 |
| Pharmacosmos Therapeutics Inc. | 3 | $87 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $72 |
| Pfizer | 4 | $72 |
| Incyte Corporation | 4 | $71 |
| Genentech USA, Inc. | 3 | $68 |
| Taiho Oncology, Inc. | 2 | $67 |
| GSK | 3 | $46 |
| Sanofi | 2 | $40 |
| AVEO Pharmaceuticals, Inc. | 2 | $31 |
| Revance Therapeutics, Inc. | 1 | $29 |
| EMD Serono, Inc. | 1 | $28 |
| Seagen Inc. | 1 | $26 |
| Sumitomo Pharma America, Inc. | 1 | $21 |
| Accord Healthcare, Inc. | 1 | $21 |
| Agios Pharmaceuticals, Inc. | 1 | $20 |
| Genmab U.S., Inc. | 1 | $19 |
| Azurity Pharmaceuticals, Inc. | 1 | $19 |
| Tersera Therapeutics LLC | 1 | $18 |
| Rigel Pharmaceuticals, Inc. | 1 | $18 |
| Pharmaand GmbH | 1 | $18 |
| Tolmar, Inc. | 1 | $18 |
| Melinta Therapeutics, LLC | 1 | $18 |
| Jazz Pharmaceuticals Inc. | 1 | $18 |
| Boehringer Ingelheim | 1 | $17 |
| Puma Biotechnology, Inc. | 1 | $17 |
| Geron Corporation | 1 | $17 |
| Blueprint Medicines Corporation | 1 | $17 |
| Caris MPI, Inc. | 1 | $16 |
| Coherus Oncology, Inc. | 1 | $16 |
| Beone Medicines USA, Inc. | 1 | $16 |
| Novocure Inc. | 1 | $15 |
| Beigene USA, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- KEYTRUDA$124
How this compares
$2,846 in reported general payments places this provider in the 95th percentile of 3,478 nurse practitioner providers in Wisconsin.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Anastrozole | 40 | $770 |
| Tamsulosin Hcl | 24 | $434 |
| Oxycodone Hcl | 15 | $363 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 20 | $321 |
Paid to pharmacies, not to this prescriber.
Other nurse practitioner in Beloit
- Cynthia CarlsonMadison$891K
- Jodi StrongStevens Point$246K
- Jo Ellen FrawleyPrairie du Sac$194K
- Trisha WilcoxMilwaukee$174K
- Sally BowaGreen Bay$117K
- Christina SauldMilwaukee$111K
- Melissa WendellWausau$98K
- Colleen TrevinoMilwaukee$94K
- Nicole BarteltWaukesha$85K
- Kari FisherPrairie du Sac$57K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.